The FDA has approved guselkumab (Tremfya) as the first IL-23 inhibitor offering both subcutaneous and intravenous induction options for adults with moderate to severe active Crohn disease.

A white model who had a subcutaneous injection to become black has revealed her intentions of moving to Africa in the next ...

AstraZeneca has signed two deals worth $1.35 billion with Alteogen to develop subcutaneous versions of the British pharma’s ...

As people get out to clean up their yards, either getting it ready for spring or cleaning up after a spring storm, they often ...

The global mesotherapy market, valued at US$ 801.2 Mn in 2023, is set to experience steady growth over the next decade. With ...

AstraZeneca is betting roughly $1.35 billion on Korean biotech Alteogen to help develop under-the-skin versions of multiple ...

The greater the number of risk factors in patients with cutaneous squamous cell carcinoma, the higher the likelihood of poor ...

FORGET a six-pack, do you just long for the day when you can do up your jeans without performing a gymnastics routine worthy ...

Feathers are among the most complex cutaneous appendages in the animal kingdom. While their evolutionary origin has been ...

Weekly subcutaneous administration of sabirnetug was well-tolerated in the Phase 1 study ; Systemic exposure following subcutaneous administration supports further clinical develo ...

Weekly subcutaneous administration of sabirnetug ... of biologics that can be delivered subcutaneously (just under the skin). By using rHuPH20, some biologics and compounds that are administered ...

The Florida Department of Health report stated that three people were infected "very rare strain of the disease." ...